New Study Links Fenbendazole to Remission or Near-Remission in Three Stage IV Cancer Patients

Fenbendazole, a low-cost veterinary antiparasitic, shows potential as an anticancer therapy. A new case series by Dr. William Makis reports three stage IV cancer patients (breast, prostate, melanoma) who self-administered fenbendazole outside conventional protocols, achieving complete or near-complete remission sustained up to three years without chemotherapy.